BACKTESTING
\bˈaktəstɪŋ], \bˈaktəstɪŋ], \b_ˈa_k_t_ə_s_t_ɪ_ŋ]\
Sort: Oldest first
-
The process of determining the validity of a VALUE ATRISK model by comparing actual profit and loss experience with results predicted by the model. The process is also applicable in investment management, where a current securities selection methodology is applied to prior periods to create a hypothetical performance history. See also PROFIT AND LOSS EXPLAIN.
By Henry Campbell Black
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.